Clinical Trial Update: Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial OPTIMUS-CABG is evaluating high- versus low-dose aspirin in combination with prasugrel as dual antiplatelet therapy after coronary artery bypass g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Stable Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o. | Conditions: Chronic Coronary Syndrome, Stable Coronary Artery Disease CAD | Phase 3 | Status: RECRUITING